87 related articles for article (PubMed ID: 31773233)
21. Prediction of Overall Survival and Progression-Free Survival by the
Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
[No Abstract] [Full Text] [Related]
22. Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging.
Carmona-Bozo JC; Manavaki R; Woitek R; Torheim T; Baxter GC; Caracò C; Provenzano E; Graves MJ; Fryer TD; Patterson AJ; Gilbert FJ
Eur Radiol; 2021 Jan; 31(1):333-344. PubMed ID: 32725330
[TBL] [Abstract][Full Text] [Related]
23.
Polverari G; Ceci F; Bertaglia V; Reale ML; Rampado O; Gallio E; Passera R; Liberini V; Scapoli P; Arena V; Racca M; Veltri A; Novello S; Deandreis D
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380754
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation.
Rühle A; Grosu AL; Wiedenmann N; Mix M; Stoian R; Niedermann G; Baltas D; Werner M; Weber WA; Kayser G; Nicolay NH
Theranostics; 2020; 10(20):9395-9406. PubMed ID: 32802199
[TBL] [Abstract][Full Text] [Related]
25. The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
Wiedenmann N; Grosu AL; Büchert M; Rischke HC; Ruf J; Bielak L; Majerus L; Rühle A; Bamberg F; Baltas D; Hennig J; Mix M; Bock M; Nicolay NH
Radiother Oncol; 2020 Sep; 150():128-135. PubMed ID: 32544609
[TBL] [Abstract][Full Text] [Related]
26. Methodological evaluation of original articles on radiomics and machine learning for outcome prediction based on positron emission tomography (PET).
Rogasch JMM; Shi K; Kersting D; Seifert R
Nuklearmedizin; 2023 Dec; 62(6):361-369. PubMed ID: 37995708
[TBL] [Abstract][Full Text] [Related]
27. A contrast-enhanced CT radiomics-based model to identify candidates for deintensified chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma patients.
Lin Y; Yang Z; Chen J; Li M; Cai Z; Wang X; Zhai T; Lin Z
Eur Radiol; 2024 Feb; 34(2):1302-1313. PubMed ID: 37594526
[TBL] [Abstract][Full Text] [Related]
28. Current Role of Delta Radiomics in Head and Neck Oncology.
Marcu DC; Grava C; Marcu LG
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768535
[TBL] [Abstract][Full Text] [Related]
29. The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.
Gallez B
Front Pharmacol; 2022; 13():853568. PubMed ID: 35910347
[TBL] [Abstract][Full Text] [Related]
30. Current Omics Trends in Personalised Head and Neck Cancer Chemoradiotherapy.
Marcu LG; Marcu DC
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834445
[TBL] [Abstract][Full Text] [Related]
31. Non-Homogeneous Tumor Growth and Its Implications for Radiotherapy: A Phenomenological Approach.
Castorina P; Castorina L; Ferini G
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207503
[TBL] [Abstract][Full Text] [Related]
32. Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer.
Lazzeroni M; Ureba A; Wiedenmann N; Nicolay NH; Mix M; Thomann B; Baltas D; Toma-Dasu I; Grosu AL
Phys Imaging Radiat Oncol; 2021 Jan; 17():100-105. PubMed ID: 33898787
[TBL] [Abstract][Full Text] [Related]
33. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.
Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS
BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615
[TBL] [Abstract][Full Text] [Related]
34. A Systematic Review of PET Textural Analysis and Radiomics in Cancer.
Piñeiro-Fiel M; Moscoso A; Pubul V; Ruibal Á; Silva-Rodríguez J; Aguiar P
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33672285
[TBL] [Abstract][Full Text] [Related]
35. Application of radiomics and machine learning in head and neck cancers.
Peng Z; Wang Y; Wang Y; Jiang S; Fan R; Zhang H; Jiang W
Int J Biol Sci; 2021; 17(2):475-486. PubMed ID: 33613106
[TBL] [Abstract][Full Text] [Related]
36. The Biological Meaning of Radiomic Features.
Tomaszewski MR; Gillies RJ
Radiology; 2021 Mar; 298(3):505-516. PubMed ID: 33399513
[No Abstract] [Full Text] [Related]
37. Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy.
Socarrás Fernández JA; Mönnich D; Leibfarth S; Welz S; Zwanenburg A; Leger S; Löck S; Pfannenberg C; La Fougère C; Reischl G; Baumann M; Zips D; Thorwarth D
Phys Imaging Radiat Oncol; 2020 Jul; 15():52-59. PubMed ID: 33043157
[TBL] [Abstract][Full Text] [Related]
38. Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.
Sörensen A; Carles M; Bunea H; Majerus L; Stoykow C; Nicolay NH; Wiedenmann NE; Vaupel P; Meyer PT; Grosu AL; Mix M
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1056-1064. PubMed ID: 31773233
[TBL] [Abstract][Full Text] [Related]
39. Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
Zschaeck S; Zöphel K; Seidlitz A; Zips D; Kotzerke J; Baumann M; Troost EGC; Löck S; Krause M
Radiother Oncol; 2021 Feb; 155():204-211. PubMed ID: 33252044
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
